A multicenter prospective study to evaluate the effect of elobixibat on spontaneous defecation without a feeling of residual stool in patients with chronic constipation who are inadequately effective with magnesium oxide, a first-line treatment for constipation.
Not Applicable
Recruiting
- Conditions
- chronic constipation
- Registration Number
- JPRN-UMIN000048397
- Lead Sponsor
- Medical corporation Irisawa Medical Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with a history of hypersensitivity to elobixibat 2) Patients with confirmed or suspected intestinal obstruction due to tumor, hernia, etc. 3) Patients suspected of having constipation due to organic disease 4) Patients taking other laxatives 5) Others who are judged by the principal investigator to be inappropriate as research subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in spontaneous bowel movements (SBM) before and after switching to study drug
- Secondary Outcome Measures
Name Time Method